Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1957 2
1958 1
1959 2
1962 1
1964 1
1968 1
1969 4
1970 4
1971 2
1972 2
1973 3
1974 2
1975 5
1976 7
1977 4
1978 2
1979 6
1980 6
1981 8
1982 11
1983 6
1984 13
1985 4
1986 1
1987 3
1988 5
1989 2
1990 2
1991 4
1992 6
1993 4
1994 1
1995 2
1996 4
1997 7
1998 5
1999 1
2000 5
2001 2
2002 3
2003 5
2004 3
2005 9
2006 8
2007 16
2008 11
2009 13
2010 17
2011 20
2012 19
2013 31
2014 20
2015 42
2016 44
2017 44
2018 44
2019 36
2020 34
2021 32
2022 34
2023 45
2024 34

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

634 results

Results by year

Filters applied: . Clear all
Page 1
Management of chronic primary pelvic pain syndromes.
Parsons BA, Baranowski AP, Berghmans B, Borovicka J, Cottrell AM, Dinis-Oliveira P, Elneil S, Hughes J, Messelink BEJ, de C Williams AC, Abreu-Mendes P, Zumstein V, Engeler DS. Parsons BA, et al. BJU Int. 2022 May;129(5):572-581. doi: 10.1111/bju.15609. Epub 2021 Oct 27. BJU Int. 2022. PMID: 34617386 Review.
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy.
Crombie JL, Graff T, Falchi L, Karimi YH, Bannerji R, Nastoupil L, Thieblemont C, Ursu R, Bartlett N, Nachar V, Weiss J, Osterson J, Patel K, Brody J, Abramson JS, Lunning M, Shah NN, Ayed A, Kamdar M, Parsons B, Caimi P, Flinn I, Herrera A, Sharman J, McKenna M, Armand P, Kahl B, Smith S, Zelenetz A, Budde LE, Hutchings M, Phillips T, Dickinson M. Crombie JL, et al. Among authors: parsons b. Blood. 2024 Apr 18;143(16):1565-1575. doi: 10.1182/blood.2023022432. Blood. 2024. PMID: 38252906
Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL.
Xu-Monette ZY, Li Y, Snyder T, Yu T, Lu T, Tzankov A, Visco C, Bhagat G, Qian W, Dybkaer K, Chiu A, Tam W, Zu Y, Hsi ED, Hagemeister FB, Wang Y, Go H, Ponzoni M, Ferreri AJM, Møller MB, Parsons BM, Fan X, van Krieken JH, Piris MA, Winter JN, Au Q, Kirsch I, Zhang M, Shaughnessy J, Xu B, Young KH. Xu-Monette ZY, et al. Among authors: parsons bm. Clin Cancer Res. 2023 Dec 1;29(23):4808-4821. doi: 10.1158/1078-0432.CCR-23-1554. Clin Cancer Res. 2023. PMID: 37728879 Free PMC article.
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial.
Kumar SK, Jacobus SJ, Cohen AD, Weiss M, Callander N, Singh AK, Parker TL, Menter A, Yang X, Parsons B, Kumar P, Kapoor P, Rosenberg A, Zonder JA, Faber E Jr, Lonial S, Anderson KC, Richardson PG, Orlowski RZ, Wagner LI, Rajkumar SV. Kumar SK, et al. Among authors: parsons b. Lancet Oncol. 2020 Oct;21(10):1317-1330. doi: 10.1016/S1470-2045(20)30452-6. Epub 2020 Aug 28. Lancet Oncol. 2020. PMID: 32866432 Free PMC article. Clinical Trial.
Multiclonal tumor origin: Evidence and implications.
Parsons BL. Parsons BL. Mutat Res Rev Mutat Res. 2018 Jul-Sep;777:1-18. doi: 10.1016/j.mrrev.2018.05.001. Epub 2018 May 6. Mutat Res Rev Mutat Res. 2018. PMID: 30115427 Free article. Review.
Arthroscopic Management of Elbow Fractures.
Fink Barnes LA, Parsons BO, Hausman M. Fink Barnes LA, et al. Among authors: parsons bo. Hand Clin. 2015 Nov;31(4):651-61. doi: 10.1016/j.hcl.2015.06.011. Epub 2015 Sep 3. Hand Clin. 2015. PMID: 26498553 Review.
Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study.
Rezazadeh A, Szabo A, Khurana A, Inwards DJ, Lunning MA, Bartlett NL, Caimi PF, Rodgers TD, Barr PM, Chowdhury SM, Epperla N, Mendries H, Hill BT, Oh TS, Karmali R, Chang JE, Goyal G, Parsons BM, Isaac KM, Portell CA, Monahan K, Siker M, King DM, Fenske TS. Rezazadeh A, et al. Among authors: parsons bm. Haematologica. 2024 May 1;109(5):1439-1444. doi: 10.3324/haematol.2023.283210. Haematologica. 2024. PMID: 37855051 Free PMC article.
The diverse roles of C-type lectin-like receptors in immunity.
Scur M, Parsons BD, Dey S, Makrigiannis AP. Scur M, et al. Among authors: parsons bd. Front Immunol. 2023 Feb 27;14:1126043. doi: 10.3389/fimmu.2023.1126043. eCollection 2023. Front Immunol. 2023. PMID: 36923398 Free PMC article. Review.
Error-corrected next generation sequencing - Promises and challenges for genotoxicity and cancer risk assessment.
Marchetti F, Cardoso R, Chen CL, Douglas GR, Elloway J, Escobar PA, Harper T Jr, Heflich RH, Kidd D, Lynch AM, Myers MB, Parsons BL, Salk JJ, Settivari RS, Smith-Roe SL, Witt KL, Yauk CL, Young R, Zhang S, Minocherhomji S. Marchetti F, et al. Among authors: parsons bl. Mutat Res Rev Mutat Res. 2023 Jul-Dec;792:108466. doi: 10.1016/j.mrrev.2023.108466. Epub 2023 Aug 27. Mutat Res Rev Mutat Res. 2023. PMID: 37643677 Free article. Review.
634 results